Focusing on IVDs can save more lives and billions in costs
With increased focus on improving the quality, efficacy, and cost-effectiveness of lab tests, the IVD industry can drive great value for patients and the economics of the healthcare system.
With increased focus on improving the quality, efficacy, and cost-effectiveness of lab tests, the IVD industry can drive great value for patients and the economics of the healthcare system.
Realistic expectations are essential when forecasting both the adoption of the device and the length of time needed for payers to reimburse for the test to ensure adequate working capital, writes Harry Glorikian.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.